Status:
RECRUITING
A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
Lead Sponsor:
AbbVie
Conditions:
Axial Spondylarthritis (r-axSpA)
Eligibility:
All Genders
18+ years
Brief Summary
Axial spondyloarthritis (axSpA) is an immune-mediated inflammatory disease primarily affecting the axial skeleton. The most frequent axSpA symptom is chronic, often inflammatory back pain that might b...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
November 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT05094128
Start Date
November 22 2021
End Date
June 1 2026
Last Update
February 2 2026
Active Locations (72)
Enter a location and click search to find clinical trials sorted by distance.
1
ACURA Rheumazentrum Baden-Bade /ID# 249751
Baden-Baden, Baden-Wurttemberg, Germany, 76530
2
Heilig, Heidelberg, DE /ID# 240492
Heidelberg, Baden-Wurttemberg, Germany, 69120
3
Rheumatologische Schwerpunktpraxis /ID# 245392
Stuttgart, Baden-Wurttemberg, Germany, 70372
4
Praxis Dr. Haas /ID# 242982
Tübingen, Baden-Wurttemberg, Germany, 72072